Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.335 USD | +0.38% | -2.55% | -32.23% |
05-13 | Ikena Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
03-12 | Ikena Oncology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.23% | 64.18M | |
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |
- Stock Market
- Equities
- IKNA Stock
- News Ikena Oncology, Inc.
- Credit Suisse Adjusts Ikena Oncology's Price Target to $13 From $16, Keeps Outperform Rating